Open letters

The European Medicines Agency (EMA) publishes open letters, usually in response to contributions and feedback from stakeholders.

Reply to open letter from Members of the European Parliament concerning COVID-19 vaccines

Response to the Institute for Quality and Efficiency in Health Care (IQWiG) and the Cochrane Collaboration on transparency of COVID-19-related activities

How useful was this page?

Add your rating
1 rating
1 rating
1 rating